Ze Hong
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Acute Myeloid Leukemia Research
Papers in
-
- Circular RNAs in diseases 4
- Histone Deacetylase Inhibitors Research 2
- Extracellular vesicles in disease 2
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- Aiqiang Dong (6 shared papers)Minjian Kong (5 shared papers)Xuebiao Li (4 shared papers)Weijing Feng (2 shared papers)Ming Ni (3 shared papers)Jin Bai (1 shared paper)Zhengyan Wang (1 shared paper)Feng Gao (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Cancer Biomarkers (1 paper)OncoTargets and Therapy (1 paper)Journal of Cardiovascular Development and Disease (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ze Hong
19 papers receiving 385 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 174
- Hematology 40
- Molecular Biology 214
- Ophthalmology 24
- Rheumatology 38
Countries citing papers authored by Ze Hong
This map shows the geographic impact of Ze Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Hong more than expected).
Fields of papers citing papers by Ze Hong
This network shows the impact of papers produced by Ze Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Hong. The network helps show where Ze Hong may publish in the future.
Co-authors
The 25 scholars most cited alongside Ze Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 50 | |
| 2 | 2022 | 46 | |
| 3 | 2020 | 39 | |
| 4 | 2013 | 37 | |
| 5 | 2022 | 35 | |
| 6 | 2012 | 34 | |
| 7 | 2016 | 28 | |
| 8 | 2016 | 21 | |
| 9 | 2017 | 20 | |
| 10 | 2017 | 19 | |
| 11 | 2018 | 12 | |
| 12 | 2022 | 11 | |
| 13 | Calmodulin regulates KCNQ2 function in epilepsy. | 2016 | 11 |
| 14 | 2022 | 10 | |
| 15 | 2017 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2016 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 0 |
About Ze Hong
Ze Hong is a scholar working on Molecular Biology, Cancer Research, Genetics, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 390 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), Genetic Associations and Epidemiology (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Extracellular vesicles in disease (2 papers), Cancer Treatment and Pharmacology (1 paper) and Water Quality Monitoring Technologies (1 paper). The work is most often cited by research in Cancer Research (174 citations), Hematology (40 citations), Molecular Biology (214 citations), Ophthalmology (24 citations) and Rheumatology (38 citations). Ze Hong has collaborated with scholars based in China and United States. Frequent co-authors include Aiqiang Dong, Minjian Kong, Xuebiao Li, Weijing Feng, Ming Ni, Jin Bai, Zhengyan Wang, Feng Gao, Shan Zhong and Bo Sun. Their work appears in journals such as Frontiers in Immunology, Cancer Biomarkers, OncoTargets and Therapy, Journal of Cardiovascular Development and Disease and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.